Clinical practice: Differential renal effects of vaso-active drugs (Kristjan Karason, Gothenburg, Sweden)

How do you identify patients according to NYHA class and what clinical characteristics are markers of poor prognosis? Learn more about the importance of central haemodynamics on renal function and factors affecting microvascular regulation and see how this influences treatment choices. Dr Karason highlights differences in inotropes and describes how levosimendan may be a preferable treatment in patients with cardiorenal syndrome due to its ability to increase glomerular filtrate rate. Dr Karason concludes with a useful summary suggesting which treatments to use in different clinical scenarios.

 

Videos (5)
Login/ Register Maximise Minimise